Overview
The main objective of the present study is to evaluate the effects of the Revie intervention on the self-esteem of patients diagnosed with an advanced cancer. A pragmatic, two-arm parallel-group, waitlist randomized controlled trial is conducted. The study takes place in the oncology department of the University Hospitals of Geneva at 3 outpatient units with 102 participants (51 per group).
Description
The main objective of the present study is to evaluate the effects of the Revie intervention on the self-esteem of patients diagnosed with an advanced cancer. The secondary objectives are to evaluate the effects of the Revie intervention on spiritual well-being, personal development, life satisfaction, and the perception of the interaction with the nurses. A pragmatic, two-arm parallel-group, waitlist randomized controlled trial (WLRCT) is conducted in which participants are randomized into (i) intervention, or (ii) waitlist control groups. The intervention group (IG) receive the Revie intervention early on and the control group (CG) the same intervention but later on (i.e., after eight weeks).This monocentric study takes place in the oncology department of the University Hospitals of Geneva (HUG) at two outpatient units. The required sample size is 102 participants (51 per group).
Eligibility
Inclusion Criteria:
- Adults 18 years with and advanced cancer,
- whose general health status is adequate for participation in the study based on a clinical assessment by the nurse / doctor; and
- who consent to participate in the study.
Exclusion Criteria:
- documented cognitive impairment that compromises capacity for discernment,
- command of French is insufficient for reading, writing, or conversing.